The predictive value of platelet-to-high density lipoprotein cholesterol ratio and white blood cell-to-mean platelet volume ratio for coronary artery disease risk in STEMI patients - Top-Institutions - MDSpire

The predictive value of platelet-to-high density lipoprotein cholesterol ratio and white blood cell-to-mean platelet volume ratio for coronary artery disease risk in STEMI patients

  • By

  • Yongxue Xie

  • Li Mao

  • Fangling Luo

  • Jianbin Pi

  • Qingjun He

  • May 29, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Foshan Hospital of Traditional Chinese Medicine
    Foshan Hospital of Traditional Chinese Medicine

    Foshan, Guangdong

    Key Differentiators

    • Cardiology

  • #2

    Heinrich Heine University Düsseldorf
    Heinrich Heine University Düsseldorf

    Düsseldorf, North Rhine-Westphalia

    Key Differentiators

    • Cardiology

  • #3

    Capital Medical University
    Capital Medical University

    Beijing, Beijing

    Key Differentiators

    • Cardiology

  • #4

    Tübingen University
    Tübingen University

    Tübingen, Baden-Württemberg

    Key Differentiators

    • Cardiology

  • #5

    Leiden University Medical Center
    Leiden University Medical Center

    Leiden, South Holland

    Key Differentiators

    • Cardiology

Original Source(s)

The predictive value of platelet-to-high density lipoprotein cholesterol ratio and white blood cell-to-mean platelet volume ratio for coronary artery disease risk in STEMI patients

  • by Yongxue Xie, Li Mao, Fangling Luo, Jianbin Pi, Qingjun He

  • May 29, 2026

Related Content

Differential biomarker responses of hemolysis, inflammation, and myocardial injury after pulsed-field pulmonary vein isolation: balloon-in-basket vs. circular catheter systems

Heterogeneous benefit of early sacubitril/valsartan initiation after PCI in elderly patients with left ventricular dysfunction: myocardial recovery and mid-term cardiovascular outcomes

Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors